Hugo Stephenson, MD

Older adults generate disproportionately high engagement in digital trial recruitment, suggesting they represent an overlooked opportunity when recruitment systems are designed around their actual behavior rather than outdated assumptions about digital capability.

As AI-driven search becomes the primary way patients discover research opportunities, the quality and structure of clinical trial registry data will determine whether transparency translates into real, equitable access.

Why discussions with patients should go deeper than data-centered dialogues—and emphasize trust, personal connections, and community engagement to foster informed choices in public health.

Clinical trials face a critical challenge: bridging the gap between patient curiosity and motivation to participate, impacting recruitment success.

The clinical trial industry has a rare opportunity to redefine its role in public health conversations.

Engaging with ineligible participants can transform a potentially negative experience into a positive one.

Understanding how the dynamics between the two play hand in hand in influencing patient recruitment and retention.

Hugo Stephenson MD examines his longing for the past with the advances of today's technology in this blog focused around sites.

A comparison of the yields and costs of online outreach methods to other recruitment techniques.